SynCardia Total Artificial Heart Achieves Successful Bridge-to-Transplant at UCSF Health (SYN)

A successful bridge-to-transplant procedure using SynCardia’s Total Artificial Heart was completed at UCSF Health on February 12, 2026. The device, implanted in a 42-year-old patient with advanced heart failure, restored cardiac output and stabilized the patient for transplant. The procedure followed a 48-hour evaluation period, with the patient scheduled for transplant within the next week. The success underscores the device’s reliability in short-term support, with hospital officials noting no device malfunction and a smooth recovery trajectory. SYN shares closed at $32.45 on February 11, 2026, up 2.1%.